Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Endoscopic Retrograde Cholangiopancreatography Market

May 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

제품별 내시경 역행성 담관췌관조영술 시장(상부 위장관 내시경, 스텐트, 풍선, 카테터, 바스켓), 시술(담관 괄약근 절개술 및 스텐트, 췌장 괄약근 절개술), 최종 사용자(병원), 지역(북미, 유럽, 아시아 태평양, 중동 및 아프리카, 남미), 2022년부터 2029년까지의 글로벌 트렌드 및 예측

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

시장 개요


글로벌 내시경 역행성 담관췌관조영술 시장은 2022년부터 2029년까지 9.7% CAGR로 성장할 것으로 예상됩니다. 2020년 11억 8천만 달러에서 2029년까지 27억 3천만 달러 이상으로 성장할 것으로 예상됩니다.

내시경 역행성 담관췌관조영술(ERCP) 장치는 바터병의 담관, 췌장 및 팽대부를 진단하고 치료하는 데 사용됩니다. 이 방법을 사용하면 조영제를 공통 간관, 췌장관 또는 낭성 동맥에 직접 주입할 수 있습니다.


담관 결석과 췌장암의 발생률이 증가함에 따라 이러한 장치에 대한 수요는 가까운 미래에 증가할 것으로 예상됩니다. 또한 최소 침습 수술 기술의 도입으로 ERCP 시술을 원하는 환자 수가 증가하여 향후 몇 년 동안 시장이 상승하는 데 도움이 될 것입니다. 2021년 1월 미국 암 협회에 따르면 담관암(담관암)은 희귀 암입니다. 미국에서 매년 약 8,000명이 이 암으로 진단받습니다. 담관은 간내(간 내부)와 간외(간 외부) 모두에 있습니다.






















































기인하다세부
학습 기간2020-2029
기준년도2021
추정 연도2022
예상 연도2022-2029
역사적 기간2018-2020
단위가치(10억 달러)
분할제품별, 절차별, 최종 사용자별
제품별로

 


  • 상부 위장내시경

  • 스텐트

  • 풍선

  • 카테터

  • 바구니


절차에 따라

 


  • 담관 괄약근 절개술 및 스텐트 삽입술

  • 췌장 괄약근 절개술


최종 사용자에 의해

 


  • 병원


지역별로

 


  • 북아메리카

  • 유럽

  • 아시아 태평양

  • 남아메리카

  • 중동 및 아프리카



People have become more interested in minimally invasive operations in recent years, rather than typical open surgeries that need large incisions through the muscles. It takes a long time for these muscles to recover. The main benefit of minimally invasive surgeries (MIS) over traditional open surgeries is higher precision due to video-assisted equipment, which produces a better and magnified image of the organs or body parts being operated on, as well as other significant benefits such as less major bleeding, fewer post-op infections, fewer complications, shorter length of stay, faster return to normal activities, less scarring, and comparable/lower cost, among others. As a result, these operations have recently grown more common.


Cancer is becoming more common over the world. According to the World Health Organization, cancer is the second biggest cause of death worldwide, accounting for 10 million deaths in 2020. According to the American Cancer Society, there will be 41,260 new instances of liver cancer and intrahepatic bile duct cancer diagnosed in the United States in 2022. Since 1980, the incidence of liver cancer has more than tripled, while the fatality rate has more than doubled. Around 60,430 new pancreatic cases were detected in the United States in 2021. Every year, around 10,500 new pancreatic cancer cases and 6,200 new liver cancer cases are diagnosed in the United Kingdom (2016-2018). In 2018, 458,918 new cases of pancreatic cancer were recorded worldwide, with 355,317 new cases expected in 2040. Because ERCP is frequently used to diagnose hepatic, bile duct, and pancreatic tumors, the increased prevalence of these malignancies has a direct impact on the ERCP market.


One of the major restraining factors for the market is the high costs of ERCP equipment and procedures. Also factor like long procedure time is obstructing the market growth.


The BRICS countries (Brazil, Russia, India, China, and South Africa) are among the world's fastest-growing economies. In 2021, emerging economies accounted for almost one-third of global healthcare spending, according to the World Economic Forum. Because India and China are home to more than half of the world's population, these countries have the biggest number of patients. The rising cancer burden, quick improvements in healthcare infrastructure, the rapid rise of medical tourism, and the presence of flexible legislation in these nations all encourage endoscopy equipment manufacturers to expand their operations in these countries.


COVID-19 팬데믹은 시장에 부정적인 영향을 미쳤습니다. COVID-19 감염은 다양한 시술을 위해 병원을 자주 찾는 외과의와 환자에게 더 큰 영향을 미칠 가능성이 높습니다. 대부분의 위장 수술이 중단되어 ERCP와 같은 장치 기반 치료가 감소했습니다. 독일 전역의 대형 병원에서 약 40~50%의 내시경 시술이 취소되었습니다. 한 연구에 따르면 COVID-19 팬데믹으로 인해 ERCP 시술이 상당히 감소했습니다. 전 세계적으로 내시경 서비스에 대한 제한으로 인해 성공률도 감소했습니다. 내시경은 에어로졸을 발생시키는 시술로 분류되어 의료진에게 전파될 위험이 있습니다.




[캡션 id="attachment_8950" 정렬="alignleft" 너비="870"]Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy
내시경 역행성 담관췌관조영술 시장 | Exactitude Consultancy
[/표제]


Frequently Asked Questions

• What is the worth of global endoscopic retrograde cholangiopancreatography market?

The endoscopic retrograde cholangiopancreatography market size had crossed 1.18 USD Billion in 2020 and will observe a CAGR of more than 9.7% up to 2029 driven by the rising technological advancements in molecular biology, genomics, and microbial diversity.

• What is the size of the North America endoscopic retrograde cholangiopancreatography industry?

North America held more than 25% of the endoscopic retrograde cholangiopancreatography market revenue share in 2020 and will witness expansion with the improved healthcare system.

• What are the upcoming trends of endoscopic retrograde cholangiopancreatography market, globally?

The upcoming trends in endoscopic retrograde cholangiopancreatography market are expansion in F&B industry, along with development in extraction technology.

• What is the CAGR of endoscopic retrograde cholangiopancreatography market?

The global endoscopic retrograde cholangiopancreatography market registered a CAGR of 9.7% from 2022 to 2029. The endotherapy devices segment was the highest revenue contributor to the market.

• Which are the top companies to hold the market share in endoscopic retrograde cholangiopancreatography market?

Key players profiled in the report include Olympus Corporation, CONMED Corporation, Fujifilm Holdings Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Boston Scientific Corporation, Johnson & Johnson, Medtronic, PLC, Cook Medical, and B. Braun Melsungen AG.

• What is the leading application of endoscopic retrograde cholangiopancreatography market?

It is used to diagnose and treat the biliary tract, pancreas, and ampulla of Vater illnesses.

• Which is the largest regional market for endoscopic retrograde cholangiopancreatography market?

Asia-Pacific is the largest regional market for endoscopic retrograde cholangiopancreatography market.

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis

On the basis of product, the market is segmented into Upper GI endoscopes, Stent, Balloons, Catheters, Baskets. Based on procedures the ERCP market is segmented into Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy.

During the forecast period, the Endo therapy devices segment held the biggest market share by product type. The growing inclination for less invasive operations and the rising prevalence of gastrointestinal diseases are two variables contributing to the Endo therapy devices segment's significant revenue.

Sphincterotomes accounted for the greatest market share in the Endo therapy devices segment throughout the projection period. This can be ascribed to an increase in biliary problems due to the rising incidence of pancreatic duct and bile duct stones, as well as the growing geriatric population.

[caption id="attachment_8951" align="alignleft" width="680"]Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy
Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy
[/caption]

Endoscopic Retrograde Cholangiopancreatography Market Players

The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation, CONMED Corporation, Fujifilm Holdings Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Boston Scientific Corporation, Johnson & Johnson, Medtronic, PLC, Cook Medical, and B. Braun Melsungen AG.

These companies have adopted various organic as well as inorganic growth strategies to strengthen their position in the market. New product development, merger & acquisition, and expansion were among the key growth strategies adopted by these leading players to enhance their product offering and regional presence and meet the growing demand for endoscopic retrograde cholangiopancreatography in the emerging economies.

Who Should Buy? Or Key stakeholders

  • Endoscopic retrograde cholangiopancreatography suppliers
  • Investors
  • Manufacturing companies
  • End-user companies
  • Research institutes
  • Medical sector
  • Environment, Health and Safety Professionals

Endoscopic Retrograde Cholangiopancreatography Market Regional Analysis

The global endoscopic retrograde cholangiopancreatography market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

  • North America: includes the US, Canada, Mexico
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • South America: includes Brazil, Argentina and Rest of South America
  • Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

During the forecast period, the Asia Pacific and Latin American markets are expected to grow at the fastest rates. The high growth in this regional market can be attributed to Japan's well-developed healthcare system, which includes universal health insurance coverage, and countries like China and India focusing on improving healthcare infrastructure to serve large populations of patients with critical illnesses, such as cancer and tumors. In addition, governments in a number of Latin American countries are working to improve their healthcare systems. Brazil's healthcare sector has seen tremendous transformations, making it one of the world's most promising and appealing sectors.

[caption id="attachment_8953" align="alignleft" width="680"]Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy
Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy
[/caption]
Key Market Segments: Global Endoscopic retrograde cholangiopancreatography Market Global Endoscopic Retrograde Cholangiopancreatography Market by Product, 2020-2029, (USD Million) (Thousand Units)
  • Upper GI Endoscopes
  • Stent
  • Balloons
  • Catheters
  • Baskets
Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure, 2020-2029, (USD Million) (Thousand Units)
  • Biliary Sphincterotomy & Stenting
  • Pancreatic Sphincterotomy
Global Endoscopic Retrograde Cholangiopancreatography Market by End-User, 2020-2029, (USD Million) (Thousand Units)
  • Hospitals
Global Endoscopic Retrograde Cholangiopancreatography Market by Region, 2020-2029, (USD Million) (Thousand Units)
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East And Africa
Important Countries In All Regions Are Covered.

  1. 소개

    1. 시장 정의

    2. 시장 세분화

    3. 연구 일정

    4. 가정 및 제한



  2. 연구 방법론

    1. 데이터 마이닝

      1. 2차 연구

      2. 1차 연구

      3. 주제별 전문가의 조언



    2. 품질 검사

      1. 최종 검토



    3. 데이터 삼각 측량

      1. 바텀업 방식

      2. 탑다운 접근 방식

      3. 연구 흐름



    4. 데이터 소스



  3. 요약

  4. 시장 개요

    1. 글로벌 내시경 역행성 담관췌관조영술 시장 전망

      1. 시장 동인

      2. 시장 제약

      3. 시장 기회



    2. COVID-19가 글로벌 내시경 역행성 담관췌관조영술 시장에 미치는 영향



  5. 제품별 글로벌 내시경 역행성 담관췌관조영술 시장(백만 달러)(천 단위)

    1. 상부 위장관 내시경

    2. 스텐트

    3. 풍선

    4. 카테터

    5. 바구니



  6. 시술별 글로벌 내시경 역행성 담관췌관조영술 시장(백만 달러)(천 단위)

    1. 담관 괄약근 절개술 및 스텐트 삽입술

    2. 췌장 괄약근 절개술



  7. 최종 사용자별 글로벌 내시경 역행성 담관췌관조영술 시장(백만 달러)(천 단위)

    1. 병원



  8. 지역별 글로벌 내시경 역행성 담관췌관조영술 시장(백만 달러)(천 단위)

    1. 소개

    2. 아시아 태평양

      1. 중국

      2. 인도

      3. 일본

      4. 대한민국

      5. 호주

      6. 동남아시아

      7. 아시아 태평양의 나머지 지역



    3. 북아메리카

      1. 미국

      2. 캐나다

      3. 멕시코



    4. 유럽

      1. 독일

      2. 영국

      3. 프랑스

      4. 이탈리아

      5. 스페인

      6. 러시아 제국

      7. 유럽의 나머지 지역



    5. 남아메리카

      1. 브라질

      2. 아르헨티나

      3. 콜롬비아

      4. 남미의 나머지 지역



    6. 중동 및 아프리카

      1. 아랍에미리트

      2. 사우디 아라비아

      3. 남아프리카 공화국

      4. 중동 및 아프리카의 나머지 지역







  1. 회사 프로필*(사업 개요, 회사 스냅샷, 제공되는 제품 유형, 최근 개발)

    1. 올림푸스 주식회사

    2. 콘메드 주식회사

    3. 후지필름홀딩스 주식회사

    4. 호야 주식회사

    5. 칼 스토르츠 SE & CO. KG

    6. 암부 A/S

    7. 보스턴 사이언티픽 코퍼레이션

    8. 존슨앤존슨

    9. 메드트로닉 주식회사

    10. 쿡 메디컬

    11. BRAUN MELSUNGEN AG *회사 목록은 표시용입니다.




 

표 목록


TABLE 1                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 2                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 3                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 4                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029
TABLE 5                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 6                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 7                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 8                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION (THOUSAND UNITS), 2020-2029

TABLE 9                NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 10              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 11              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 12              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 13              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 14              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 15              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 16              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 17              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 18              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 19              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 20              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 21              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 22              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 23              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (MILLIONS), 2020-2029

TABLE 24              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 25              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 26              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 27              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 28              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 29              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 30              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 31              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 32              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 33              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 34              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 35              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 36              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 37              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 38              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 39              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 40              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 41              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 42              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 43              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 44              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 45              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 46              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 47              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 48              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 49              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 50              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 51              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 52              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 53              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 54              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 55              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 56              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 57              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 58              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 59              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 60              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 61              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 62              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 63              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 64              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 65              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 66              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 67              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 68              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 69              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 70              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 71              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 72              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 73              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 74              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 75              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 76              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 77              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 78              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 79              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 80              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 81              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 82              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 83              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 84              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 85              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 86              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 87              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 88              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 89              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 90              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 91              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 92              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 93              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 94              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 95              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 96              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 97              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 98              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 99              AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 100            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 101            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 102            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 103            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 104            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 105            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 106            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 107            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 108            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 109            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 110            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 111            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 112            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 113            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 114            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 115            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 116            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 117            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 118            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 119            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 120            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 121            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 122            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 123            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 124            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 125            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 126            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 127            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 128            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 129            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 130            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 131            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 132            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 133            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 134            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 135            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 136            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 137            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 138            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 139            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 140            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 141            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 142            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 143            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 144            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 145            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 146            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 147            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 148            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 149            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 150            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 151            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 152            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 153            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 154            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 155            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 156            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 157            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 158            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 159            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 160            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 161            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 162            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 163            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 164            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 165            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 166            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 167            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 168            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 169            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 170            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 171            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 172            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 173            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 174            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 175            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 176            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 177            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 178            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 179            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 180            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 181            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 182            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 183            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 184            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 185            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 186            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 187            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 188            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 189            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 190            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 191            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 192            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 193            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 194            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 195            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 196            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 197            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 198            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

 

LIST OF FIGURES


FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 9             GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, USD MILLION, 2020-2029

FIGURE 10           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 11           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 14           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, USD MILLION, 2020-2029

FIGURE 15           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 16           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 17           ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION 2021

FIGURE 18           MARKET SHARE ANALYSIS

FIGURE 19           OLYMPUS CORPORATION: COMPANY SNAPSHOT

FIGURE 20           CONMED CORPORATION: COMPANY SNAPSHOT

FIGURE 21           FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT

FIGURE 22           HOYA CORPORATION: COMPANY SNAPSHOT

FIGURE 23           KARL STORZ SE & CO. KG: COMPANY SNAPSHOT

FIGURE 24           AMBU A/S: COMPANY SNAPSHOT

FIGURE 25           BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 26           JOHNSON & JOHNSON, MEDTRONIC PLC: COMPANY SNAPSHOT

FIGURE 27           COOK MEDICAL: COMPANY SNAPSHOT

FIGURE 28           B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
2687

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.